Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573774
"Body, Mind, and Self: ACT With Psychoeducation for Female Students Facing Eating Challenges"Menoufia UniversityCompletedNot Applicable
NCT07573774Completed
Not Applicable
"Body, Mind, and Self: ACT With Psychoeducation for Female Students Facing Eatin...Menoufia University
NCT07571941
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy UniversityNot Yet Recruiting
NCT07571941Not Yet Recruiting
—
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy Universit...
NCT07572604
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not Yet RecruitingNot Applicable
NCT07572604Not Yet Recruiting
Not Applicable
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver Na...
NCT07574294
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca TrevigianaCompleted
NCT07574294Completed
—
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca Trev...
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07572318
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometry on a VERITON™ CZT CameraCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07572318Not Yet Recruiting
Not Applicable
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometr...Central Hospital, Nancy,...
NCT07574385
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine IncRecruitingPhase 2
NCT07574385Recruiting
Phase 2
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine Inc
NCT07573878
Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.Riphah International UniversityCompletedNot Applicable
NCT07573878Completed
Not Applicable
Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.Riphah International Univ...
NCT07572591
Ultrasound for Peripheral Nerve ModulationStanford UniversityNot Yet RecruitingNot Applicable
NCT07572591Not Yet Recruiting
Not Applicable
Ultrasound for Peripheral Nerve ModulationStanford University
NCT07573371
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University HospitalRecruiting
NCT07573371Recruiting
—
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University Hospit...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07572669
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRecruitingPhase 2
NCT07572669Recruiting
Phase 2
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogen...Union Hospital, Tongji Me...
NCT07573800
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International UniversityNot Yet RecruitingNot Applicable
NCT07573800Not Yet Recruiting
Not Applicable
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International Univ...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572058
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLCNot Yet RecruitingNot Applicable
NCT07572058Not Yet Recruiting
Not Applicable
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLC
NCT07572019
Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical ThoracoscopyKafrelsheikh UniversityNot Yet RecruitingPhase 2
NCT07572019Not Yet Recruiting
Phase 2
Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical Thor...Kafrelsheikh University
NCT07573839
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature FusionShanghai Mental Health CenterRecruiting
NCT07573839Recruiting
—
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Us...Shanghai Mental Health Ce...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed3 (15%)
not_applicable10 (50%)
Not Specified5 (25%)
Phase 25 (25%)